Trial intelligence / Profile preview

CO-HO-RT: Concurrent vs Sequential Letrozole and Radiotherapy in Breast Cancer

NCT00208273Phase 2Completed

Sponsor
Institut du Cancer de Montpellier
Start
Jan 2005
Primary completion
Jan 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of letrozole in breast cancer, sponsored by Institut du Cancer de Montpellier. Started Jan 2005; status: completed.

02

Drugs

letrozole
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00208273.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00208273.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call